Drug safety evaluation of naltrexone/bupropion for the treatment of obesity

By Verpeut Jessica L   Bello Nicholas T  

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 831-841

Informa Healthcare

Access to resources Recommend Favorite

Bupropion SR for smoking cessation

By West Robert  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 533-540

Informa Healthcare

Access to resources Recommend Favorite

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

By Plodkowski Raymond A   Nguyen Quang   Sundaram Umasankari   Nguyen Loida   Chau Diane L   St Jeor Sachiko  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1069-1081

Informa Healthcare

Access to resources Recommend Favorite

Bupropion SR worsens mood during marijuana withdrawal in humans

By Haney Margaret   Ward Amie   Comer Sandra   Hart Carl   Foltin Richard   Fischman Marian  

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 171-179

Springer Publishing Company

Access to resources Recommend Favorite

Sustained-release (SR) bupropion appears to reduce gambling behaviour in pathological gamblers

By  

Inpharma, Vol. 1, Iss. 1514, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite